BUENA PARK, CA--(Marketwire - April 06, 2011) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today that the Company projects revenue growth of 200 percent in 2011. The growth is expected due to a major manufacturing and marketing expansion of the SOHM Brand of diabetic products in India. The launch of a full range of anti-diabetic products in the states of Gujarat and Chattisgarh is anticipated to have a significant impact on revenue growth through Q4 of 2011.
India is expected to become the diabetic capital of the world in the year 2015 as the number of diabetic patients increases yearly. The present market size of diabetic products in India is Rs. 2,500 crore, over $500 Million USD, with a growth rate of 29 percent per year.
Shailesh Shah, President and CEO of SOHM, Inc. stated, “Our team in India has worked diligently to prepare and launch our product line for the Indian diabetes market. Diabetes in India has long passed the stage of an epidemic and numbers have given the country the dubious distinction of diabetes capital of the world. Manufacturing and distributing generic anti-diabetic products is our way of helping in this growing public health problem. This is a great opportunity for SOHM to build our business and make a massive difference to the lives of people in urgent need of affordable generic pharmaceutical drugs.”
About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com
Safe Harbor Statement
This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
Investor Relations
(714) 522-6700
Email Contact
